ResearcherErasmus MCNo recent work listed
Henri Braat
Matched on ORCID iD 0000-0002-9954-0255; OpenAlex author ID A5061559272. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2012: 1 paper · 2013: none · 2014: 2 papers
Papers 3
- mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. Last author DOI 10.1016/j.canlet.2014.01.014↗
- Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. First author DOI 10.1016/j.ctrv.2013.11.005↗
- Pancreatic cancer: promise for personalised medicine? Co-author DOI 10.1016/j.canlet.2011.11.034↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maikel Petrus Peppelenbosch · 3 shared papers, 2012–2014 · strength 0.14
- Paper mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. DOI 10.1016/j.canlet.2014.01.014↗
- Paper Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. DOI 10.1016/j.ctrv.2013.11.005↗
- Paper Pancreatic cancer: promise for personalised medicine? DOI 10.1016/j.canlet.2011.11.034↗
- Marco J. Bruno · 3 shared papers, 2012–2014 · strength 0.14
- Paper mTOR is a promising therapeutical target in a subpopulation of pancreatic adenocarcinoma. DOI 10.1016/j.canlet.2014.01.014↗
- Paper Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. DOI 10.1016/j.ctrv.2013.11.005↗
- Paper Pancreatic cancer: promise for personalised medicine? DOI 10.1016/j.canlet.2011.11.034↗
- Casper H.J. van Eijck · 2 shared papers, 2014 · strength 0.09
- Wesley K. Utomo · 1 shared paper, 2014 · strength 0.05
- Kostandinos Sideras · 1 shared paper, 2014 · strength 0.05
- Jaap Kwekkeboom · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.